Search CHA
Drug Safety Executive Council
Home
About Collaborative Projects
Current Collaborative Projects - Enrollment Open
Assessing GLP Compliance and Quality Practices in China
Project Leadership
About Collaborative Projects
Current Collaborative Projects - Enrollment Open
Evaluating Preclinical Cardio-Toxicity Assessment Tools
Leveraging Biomarker & Translational Research in China
Assessing GLP Compliance and Quality Practices in China
Exploiting Legacy Safety Studies
Assessing the Asian Supply Chain of Non-Human Primates (NHPs)
Case Studies of Past CHA Projects
Project Leadership
Ernie Bush, Ph.D., Vice President & Scientific Director
Dr. Bush has spent over 23 years working in the field of biomedical R&D most of which working in preclinical safety departments for major pharmaceutical companies. From 1992 to 2005 he worked at Hoffmann-La Roche, Inc. and for the last 5 years of that time he led their Non-Clinical Drug Safety Department. This department of approximately 120 members was comprised of the following functional groups: Drug Metabolism, Non-Clinical Pharmacokinetics, Bioanalytical, Toxicology (including Safety Pharmacology and Teratology), and Pathology. The scope of their responsibilities spanned from early Discovery support through to NDA with particular emphasis on providing an
integrated
safety assessment to projects across all phases of Discovery and Development. His in-depth knowledge and broad experience in both the informatics and safety assessment fields has made him a unique leader in today’s complex drug development landscape. Contact Ernie at 781-320-4018 or contact him by
email
.
Eric Meyers, Vice President, Global Initiatives & Project Director
Eric Meyers is project leader for CHA’s multi-company, collaborative projects with focus on China, India and other emerging markets. Eric is the also the author of the best selling industry reports
Globalization of Drug Development: China
and
Globalization of Drug Development: India
and is a frequent visitor of both countries.
Mr. Meyers joined the Cambridge Healthtech Associates from 3rd Millennium, Inc., a leading informatics consultancy to the biopharmaceutical industry. As Chief Operating Officer from 1999 to 2005, he helped the company achieve market leadership, successful service line extensions, and sustained profitability. His functional responsibilities included strategic planning, project management, third party relationships, organizational development and human resources. Prior to 3rd Millennium, Eric was Vice President of Marketing and Sales at HealthShare Technology, a venture-backed healthcare software company acquired by WebMD. Prior to HealthShare Technology, Eric spent seven years at Hewlett-Packard where he held various management positions in operations, product management, and market development of its medical products business unit. Eric Meyers received both an MBA and a B.A. from Harvard University. Contact Eric at 781-320-4007 or contact him by
email
.
Download full Project Description
Contact Us
Previous Page
Back to Project Description
Next Page